Bridger Management »

AtriCure shares owned by Bridger Management

Quarter-by-quarter ownership of AtriCure (ATRC) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in AtriCure

Tip: Access up to 7 years of quarterly data

All positions including AtriCure held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AtriCure by Bridger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 87k 35.69
2019-12-31 $8.5M 262k 32.51

More positions owned by Bridger Management

Uber Technologies (UBER)
Godaddy Cl A (GDDY)
Caesars Entertainment (CZR)
Vertex Pharmaceuticals Incorporated (VRTX)
Morgan Stanley Com New (MS)
Eli Lilly & Co. (LLY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Bath &#38 Body Works In (BBWI)
Us Foods Hldg Corp call (USFD)
Endeavor Group Hldgs Cl A Com (EDR)
Charter Communications Inc N Cl A (CHTR)
Pfizer (PFE)
Docebo (DCBO)
Crown Holdings (CCK)
Xenon Pharmaceuticals (XENE)

View all positions for Bridger Management

Top funds holding AtriCure

Vanguard Group
Alliancebernstein
First Light Asset Management
Wellington Management Company
Fred Alger Management
Dimensional Fund Advisors
Credit Suisse
TimesSquare Capital Management
Fiera Capital Corporation
Bellevue Group
Jennifer Ranahan
Neuberger Berman Group
Daniel D. Thurber
Millennium Management
Bnp Paribas Investment Partners

View all funds holding AtriCure